Easier Access To Life-Saving Asthma Inhalers Now A Reality
Press Release: Asthma and Respiratory Foundation
Tens of thousands of New Zealanders living with asthma are set to benefit from long-awaited changes that will make it easier to access essential, lifesaving treatment, marking a major step forward for asthma care in New Zealand.
Effective from August 1, people who use a 2-in-1 inhaler to manage their asthma will be able to collect a three-month supply in a single pharmacy visit, rather than returning monthly for repeats. This change is expected to benefit about 120,000 New Zealanders.
The move directly aligns with the New Zealand Adolescent and Adult Asthma Guidelines, which are developed and maintained by the Asthma and Respiratory Foundation NZ. The guidelines recommend the 2-in-1 inhaler as the frontline treatment for most adolescents and adults with asthma, used both as a preventer and a reliever.
Foundation Chief Executive Ms Letitia Harding says this decision will make a huge difference to the 1 in 8 Kiwis living with asthma.
"When someone is having an asthma attack, they need treatment immediately - there's no time to get a prescription filled.
"Patients often need to keep their reliever inhaler in multiple places - at home, school, work, their car - so enhancing access to life-saving asthma medicine will undoubtedly reduce the morbidity of asthma in New Zealand."
The change would make asthma management significantly easier, particularly for families facing transport barriers or juggling multiple repeat prescriptions, Ms Harding says.
"When you have to visit the pharmacy every month, it becomes a real burden.
"Allowing people to collect three months' supply at once removes that hurdle and supports better treatment adherence."
Foundation Medical Director Professor Bob Hancox says the move is a good example of evidence-based, patient-centred care.
"For the past five years, our guidelines have recommended 2-in-1 anti-inflammatory reliever inhalers for most adults and adolescents with asthma, as they are much better for preventing exacerbations than the traditional blue relievers.
"As well as benefiting patients, this decision will reduce the burden on the health system by preventing asthma exacerbations and hospital admissions."
Pharmac is also proposing that medical centres be allowed to supply a number of inhalers directly under a Practitioners Supply Order (PSO), enabling healthcare practitioners to supply patients with inhalers for emergency treatment.
These changes come at a critical time. New Zealand continues to have some of the highest asthma rates in the developed world, with 1 in 8 people affected and 96 deaths each year (almost 2 people each week).
The total economic cost of asthma to New Zealand's health system is estimated at $1.2 billion annually.
© Scoop Media
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scoop
5 hours ago
- Scoop
Faster, More Accurate Brain Tumour Diagnoses For Kiwis
Minister of Health More than 100 New Zealanders have already benefited from a groundbreaking diagnostic tool that is delivering faster, more accurate brain tumour diagnoses, Health Minister Simeon Brown says. DNA methylation profiling, the international gold standard for diagnosing brain tumours, has been rolled out at Auckland City Hospital over the past year. 'This technology is a game-changer for brain tumour diagnosis in New Zealand. It enables doctors to pinpoint the exact tumour type with greater precision and in less time, meaning patients can start the right treatment sooner,' Mr Brown says. 'Until now, diagnosis was typically made by microscopic examination. In some complex cases, samples were sent overseas for methylation profiling, but that could take up to six weeks. 'Having this cutting-edge capability in New Zealand means more Kiwi patients can access this advanced diagnostic technology locally. Turnaround times are faster, around four weeks, and quicker for urgent cases. 'It also means we can prioritise urgent cases, deliver answers sooner, and give patients and their families greater certainty.' In some recent cases done locally, methylation profiling has significantly altered the initial diagnosis. In others, it has identified rare or unexpected tumour types that may have been missed using traditional methods. The Auckland-based service is one of only three in Australasia, with samples from hospitals around the country also being sent to Auckland for analysis. Along with improving access and outcomes for patients, it is also significantly cheaper than sending samples offshore. 'Delivering faster access to cancer treatment is a key focus for the Government, which is why it is one of our five national health targets. Faster, more accurate diagnosis for brain tumours that may be cancerous is a vital part of that. 'By providing local access to the world's best diagnostic tools, we are improving outcomes for New Zealanders,' Mr Brown says.
NZ Herald
a day ago
- NZ Herald
The shocking roadblocks to timely cardiac care in New Zealand
Listening to articles is free for open-access content—explore other articles or learn more about text-to-speech. Study puts the total cost of heart disease deaths in 2020 at $13.09 billion. Image / Getty Images The Kia Manawanui Trust has shone a shocking spotlight on the roadblocks to timely cardiac care in New Zealand, but members are optimistic things can be fixed. Cardiac care in New Zealand is in trouble. There are extensive delays for surgery, a shortage of specialists, long waits for scans, and lack of access to drugs that would help heart patients. Two years ago, officials considered sending patients to Australia for treatment because the situation here was so dire, and not for the first time. The Kia Manawanui Trust (it means 'the heart of Aotearoa') is out to try to make a difference. A sister charity to the Asthma and Respiratory Foundation, it set out in 2018 to identify the problems and find ways to fix them. 'This is a major killer in New Zealand,' says CEO Letitia Harding. 'We're going to find out where the bottlenecks are, what lobbying needs to be done, why we don't have devices and medical interventions you can get overseas that we know save lives, and we're going to start raising awareness and pushing for change.' One of the trust's first successes was to raise funds for portable electrocardiogram (ECG) machines to be sent to under-served communities. It has also run a certified course in intravascular imaging, a technique that can significantly reduce cardiac death as it allows doctors to see inside blood vessels to assess the severity of disease. Now, it has funded research by Otago University which has pinpointed just how badly heart care in New Zealand is lagging. Almost half of all heart attack patients are not being treated within internationally accepted timeframes, the 'Heart Disease in Aotearoa' report found. Areas with the fewest cardiac specialists – Tairāwhiti, Whanganui and the central North Island – have the highest death rates. Māori and Pasifika are hospitalised or die from heart disease on average a decade earlier than the population as a whole. Auckland is the only region where the number of specialists per head of population is comparable to European countries. The study put the total cost of heart disease deaths in 2020 at $13.09 billion. 'The lack of investment in the cardiac space has been going on for many, many years,' says Harding. 'I don't blame one government or the other, this has been decades. 'We're going to make some noise and come up with solutions.' Harding says it isn't such a stretch for a charity focused on respiratory health to become involved with cardiac care, too. 'The heart and lungs are related,' she points out. 'We know that COPD [chronic obstructive pulmonary disease] can lead to heart failure, for instance. And when the Asthma and Respiratory Foundation was talking about vaping issues, more and more literature was coming out on how it affects not just the lungs but the heart.' In a bid to tackle the shortage of cardiac sonographers, Te Whatu Ora Health New Zealand has already partnered with the University of Auckland to launch a training programme for at least 15 students per year. However, during their studies they need to train in a cardiology department, and Harding says there's no budget for that. Ringfencing funding is among a list of solutions the trust has suggested to Health Minister Simeon Brown. Kia Manawanui also wants to see more funding for dedicated cardiac beds at hospitals in main centres, an end to delays in hiring new medical staff when someone leaves a hospital position, and a commitment to tackling the waitlist for ECGs. The trust estimates at least 15,000 patients are waiting for heart scans to diagnose potentially life-threatening conditions and has called for locum staff to be used to run extra clinics to clear the backlog. Particularly in rural areas, there are delays for patients who need heart scans that could detect atrial fibrillation early. The condition can lead to heart failure and affects about one in 35 Kiwis. Te Whatu Ora has announced plans to shorten hospital waiting lists by outsourcing simpler 'elective' procedures to private surgeons. Harding agrees this could ease the pressure on the health system. 'But private hospitals don't do acute services. They aren't going to be seeing the heart attack patients at 3am – they go to the public hospital. 'There is a place for the public-private partnership model this government is obviously very keen on. But you still have to invest in secondary hospitals that are screaming out for more beds.' Harding is optimistic that the trust can make a difference. 'There was a need for someone to speak out about the issues going on in the cardiac space. Heart disease affects so many lives and we're really excited to get into this new area.'
NZ Herald
2 days ago
- NZ Herald
Bowel screening uptake in Bay of Plenty appalling
It is a similar story in the Lakes health district, covering Taupō and Rotorua, where 27,694 were sent between August 1, 2022, and May 26, 2025. Of those, only 15,039 were returned. These figures are alarming because New Zealand has one of the world's highest bowel cancer rates, and it is the second-highest cause of cancer. That means an average of about eight people a day are being told they have it. It's not just an older person's cancer either, because more than 350 people under 50 are diagnosed annually. Many people know someone who has survived bowel cancer or died from it, and much has been done over the past eight years to try to get in front of the problem. The National Bowel Screening Programme started in July 2017 and has been introduced by all the former 20 district health boards, with Bay of Plenty being the last. People are invited to join the programme at 60, and are then sent a free home-test kit every two years until the age of 74. The Government is lowering the eligibility age to 58 nationwide from March. It has, however, been criticised for axing plans to lower the age for Māori and Pacific people to 50. The national charity Bowel Cancer New Zealand wants the screening age lowered to match Australia, where it is 45. It is, understandably, unhappy with the Government's slow progress. The media and advertising also play important roles in raising awareness. There are countless news articles in the media, and the national bowel screening multimedia campaign launched in July 2022 encourages people to take part in screening, emphasising it is free, quick and simple, 'and you can do it at home'. The good news is that Health NZ credits the campaign with raising awareness. But perhaps among the most powerful weapons for raising awareness are the individual patient stories. Kiwis such as Tauranga survivor Rachael Ferguson, who was 32 when she was diagnosed with stage 4 bowel cancer in December 2020. She has been 'clear' since surgery in February 2021. Then there's Rotorua father Matthew Keogan, who was 49 when he was diagnosed in 2021. He was told to get his affairs in order and say goodbye to his family as he might live only another three to six months. He has made a miraculous recovery after chemotherapy and immunotherapy with pembrolizumab (Keytruda). Last month, Northland's Cheryl Waaka, a former Black Fern and mother of two teenagers, talked about facing her toughest opponent yet: stage 4 bowel cancer. There are plenty of other personal stories on Bowel Cancer NZ's website, each offering an insight into that person's journey, each offering hope and each helping drive a greater understanding. All these people are brave and inspirational. So, given there's been a national screening campaign, heightened awareness, personal stories, and a lowering of the screening age, a reasonable question remains: Why would people fail to do something simple that costs them nothing but could save their lives? Reasons could include fear, stigma and people simply not wanting to go through what they perceive as the unpleasant procedure of having to collect samples and send them off. However, it would be fair to say some people probably can't be bothered, are ignorant or believe it won't happen to them. Whatever the reasons, the Bay of Plenty and Lakes figures are appalling. As survivor Rachael Ferguson rightly says, there are 'so many people under the age of 60 that are screaming out to have those kits' that eligible people not returning them is simply 'wasted resources'. The Government needs to lower the screening age further. At the same time, everyone eligible needs to take up the offer. It could save their lives. Bowel Cancer NZ chief executive Peter Huskinson has the final word. 'That free test in your mailbox doesn't just detect cancer – it can stop it before it starts,' he says. 'Don't leave it in a drawer. Put it by the loo and get it done.' Wise words indeed. Sign up to the Daily H, a free newsletter curated by our editors and delivered straight to your inbox every weekday.
